Rebamipide Contributes to Reducing Adverse Effects of Long-Term Administration of Omeprazole in Rats-Reference-Cited by-同舟云学术

Rebamipide Contributes to Reducing Adverse Effects of Long-Term Administration of Omeprazole in Rats

Published:2007-03-07 Issue:4 Volume:52 Page:988-994
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Hagiwara Tadashi,Mukaisho Ken-ichi,Ling Zhi-Qiang,Sakano Takayo,Sugihara Hiroyuki,Hattori Takanori

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10620-006-9415-7.pdf

Reference34 articles.

1. Kuipers EJ, Uyterlinde AM, Pena AS, Hazenberg HJ, Bloemena E, Lindeman J, Klinkenberg-Knol EC, Meuwissen SG (1995) Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety. AM J Gastroenterol 90:1401–1406

2. Yoshimura K, Delbarre SG, Kraus E, Boland CR (1996) The effects of omeprazole and famotidine on mucin and PGE2 release in the rat stomach. Aliment Pharmacol Ther 10:111–117

3. Viste A, Ovrebo K, Maartmann-Moe H, Waldum H (2004) Lanzoprazole promotes gastric carcinogenesis in rats with duodenogastric reflux. Gastric Cancer 7:31–35

4. Wetscher GJ, Hinder RA, Smyrk T, Perdikis G, Adrian TE, Profanter C (1999) Gastric acid blockade with omeprazole promotes gastric carcinogenesis induced by duodenogastric reflux. Dig Dis Sci 44:1132–1135

5. Stolte M, Bethke B, Ruhl G, Ritter M (1992) Omeprazole-induced pseudohypertrophy of gastric parietal cells. Z Gastroenterol 30:134–138

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting SIRT1/FoxO3a/Nrf2 and PI3K/AKT Pathways with Rebamipide Attenuates Acetic Acid-Induced Colitis in Rats;Pharmaceuticals;2023-04-02

2. Pharmacologic treatment of GERD: Where we are now, and where are we going?;Annals of the New York Academy of Sciences;2020-09-15

3. Potential proton pump inhibitor–related adverse effects;Annals of the New York Academy of Sciences;2020-08-06

4. The Benefits of Combination Therapy with Esomeprazole and Rebamipide in Symptom Improvement in Reflux Esophagitis: An International Multicenter Study;Gut and Liver;2016-11-15

5. Histopathological and Immunohistochemical Characterization of Methyl Eugenol–induced Nonneoplastic and Neoplastic Neuroendocrine Cell Lesions in Glandular Stomach of Rats;Toxicologic Pathology;2014-12-01